{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:11:13Z","timestamp":1786119073418,"version":"build-2736575974"},"reference-count":168,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,1]]},"DOI":"10.1097\/pap.0b013e3181916029","type":"journal-article","created":{"date-parts":[[2008,12,18]],"date-time":"2008-12-18T03:44:54Z","timestamp":1229571894000},"page":"40-55","source":"Crossref","is-referenced-by-count":40,"title":["Epstein-Barr Virus in Lymphoproliferative Processes"],"prefix":"10.1097","volume":"16","author":[{"given":"Siok-Bian","family":"Ng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph D.","family":"Khoury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-4-20210202","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/S0140-6736(64)91524-7","article-title":"Virus particles in cultured lymphoblasts from Burkitt's lymphoma","volume":"1","author":"Epstein","year":"1964","journal-title":"Lancet"},{"key":"R2-4-20210202","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0168-1702(01)00436-1","article-title":"Epstein-Barr virus","volume":"82","author":"Rickinson","year":"2002","journal-title":"Virus Res"},{"key":"R3-4-20210202","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1073\/pnas.59.1.94","article-title":"Relation of Burkitt's tumor-associated herpes-type virus to infectious mononucleosis","volume":"59","author":"Henle","year":"1968","journal-title":"Proc Natl Acad Sci USA"},{"key":"R4-4-20210202","doi-asserted-by":"crossref","first-page":"3182","DOI":"10.1001\/jama.1990.03440230078037","article-title":"Tumors of smooth-muscle origin in HIV-infected children","volume":"263","author":"Chadwick","year":"1990","journal-title":"JAMA"},{"key":"R5-4-20210202","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1056\/NEJM198803243181203","article-title":"T-cell lymphomas containing Epstein-Barr viral DNA in patients with chronic Epstein-Barr virus infections","volume":"318","author":"Jones","year":"1988","journal-title":"N Engl J Med"},{"key":"R6-4-20210202","first-page":"86","article-title":"Epstein-Barr viral DNA in tissues of Hodgkin's disease","volume":"129","author":"Weiss","year":"1987","journal-title":"Am J Pathol"},{"key":"R7-4-20210202","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/S0140-6736(82)92740-4","article-title":"Outbreak of Burkitt's-like lymphoma in homosexual men","volume":"2","author":"Ziegler","year":"1982","journal-title":"Lancet"},{"key":"R8-4-20210202","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1038\/2281056a0","article-title":"EBV DNA in biopsies of Burkitt tumours and anaplastic carcinomas of the nasopharynx","volume":"228","author":"zur Hausen","year":"1970","journal-title":"Nature"},{"key":"R9-4-20210202","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.humpath.2007.10.030","article-title":"Epstein-Barr virus-associated epithelial and mesenchymal neoplasms","volume":"39","author":"Deyrup","year":"2008","journal-title":"Hum Pathol"},{"key":"R10-4-20210202","article-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. 4th ed","author":"Swerdlow","year":"2008"},{"key":"R11-4-20210202","first-page":"2575","article-title":"Fields Virology. 4th ed","author":"Rickinson","year":"2001"},{"key":"R12-4-20210202","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/0092-8674(86)90803-2","article-title":"The structure of the termini of the Epstein-Barr virus as a marker of clonal cellular proliferation","volume":"47","author":"Raab-Traub","year":"1986","journal-title":"Cell"},{"key":"R13-4-20210202","doi-asserted-by":"crossref","first-page":"4510","DOI":"10.1073\/pnas.81.14.4510","article-title":"Epstein-Barr virus receptor of human B lymphocytes is the C3d receptor CR2","volume":"81","author":"Fingeroth","year":"1984","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R14-4-20210202","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1128\/JVI.55.2.347-351.1985","article-title":"Identification and characterization of the Epstein-Barr virus receptor on human B lymphocytes and its relationship to the C3d complement receptor (CR2)","volume":"55","author":"Nemerow","year":"1985","journal-title":"J Virol"},{"key":"R15-4-20210202","doi-asserted-by":"crossref","first-page":"4657","DOI":"10.1128\/JVI.71.6.4657-4662.1997","article-title":"Epstein-Barr virus uses HLA class II as a cofactor for infection of B lymphocytes","volume":"71","author":"Li","year":"1997","journal-title":"J Virol"},{"key":"R16-4-20210202","doi-asserted-by":"crossref","first-page":"6324","DOI":"10.1128\/JVI.74.14.6324-6332.2000","article-title":"Epstein-Barr virus gH is essential for penetration of B cells but also plays a role in attachment of virus to epithelial cells","volume":"74","author":"Molesworth","year":"2000","journal-title":"J Virol"},{"key":"R17-4-20210202","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1006\/viro.2000.0531","article-title":"Epstein-Barr virus lacking glycoprotein gp85 cannot infect B cells and epithelial cells","volume":"276","author":"Oda","year":"2000","journal-title":"Virology"},{"key":"R18-4-20210202","doi-asserted-by":"crossref","first-page":"4371","DOI":"10.1128\/JVI.72.5.4371-4378.1998","article-title":"Cell-to-cell contact as an efficient mode of Epstein-Barr virus infection of diverse human epithelial cells","volume":"72","author":"Imai","year":"1998","journal-title":"J Virol"},{"key":"R19-4-20210202","doi-asserted-by":"crossref","first-page":"865","DOI":"10.4049\/jimmunol.146.3.865","article-title":"Expression of CR2 (the C3dg\/EBV receptor, CD21) on normal human peripheral blood T lymphocytes","volume":"146","author":"Fischer","year":"1991","journal-title":"J Immunol"},{"key":"R20-4-20210202","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1002\/eji.1830180823","article-title":"Expression of CR2\/EBV receptors on human thymocytes detected by monoclonal antibodies","volume":"18","author":"Tsoukas","year":"1988","journal-title":"Eur J Immunol"},{"key":"R21-4-20210202","first-page":"2511","article-title":"Fields Virology. 4th ed","author":"Kieff","year":"2001"},{"key":"R22-4-20210202","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1158\/1078-0432.CCR-0670-3","article-title":"Epstein-Barr virus and cancer","volume":"10","author":"Thompson","year":"2004","journal-title":"Clinical Cancer Research"},{"key":"R23-4-20210202","first-page":"2343","article-title":"Fields Virology. 3rd ed","author":"Kieff","year":"1996"},{"key":"R24-4-20210202","doi-asserted-by":"crossref","first-page":"4481","DOI":"10.1128\/JVI.73.5.4481-4484.1999","article-title":"The proto-oncogene c-myc is a direct target gene of Epstein-Barr virus nuclear antigen 2","volume":"73","author":"Kaiser","year":"1999","journal-title":"Virology"},{"key":"R25-4-20210202","doi-asserted-by":"crossref","first-page":"3068","DOI":"10.1128\/JVI.70.5.3068-3074.1996","article-title":"The amino-terminal domains of Epstein-Barr virus nuclear proteins 3A, 3B, and 3C interact with RBPJ(kappa)","volume":"70","author":"Robertson","year":"1996","journal-title":"J Virol"},{"key":"R26-4-20210202","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/0014-4827(91)90438-Z","article-title":"Co-localization of the retinoblastoma protein and the Epstein-Barr virus-encoded nuclear antigen EBNA-5","volume":"197","author":"Jiang","year":"1991","journal-title":"Experimental Cell Res"},{"key":"R27-4-20210202","doi-asserted-by":"crossref","first-page":"5108","DOI":"10.1038\/sj.onc.1206556","article-title":"Epstein-Barr virus and oncogenesis: from latent genes to tumours","volume":"22","author":"Young","year":"2003","journal-title":"Oncogene"},{"key":"R28-4-20210202","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1126\/science.286.5438.300","article-title":"Mimicry of CD40 signals by Epstein-Barr virus LMP1 in B lymphocyte responses","volume":"286","author":"Uchida","year":"1999","journal-title":"Science"},{"key":"R29-4-20210202","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.2741\/2000","article-title":"Epstein-Barr virus (EBV) and its associated human cancers-Genetics, epigenetics, pathobiology and novel therapeutics","volume":"11","author":"Tao","year":"2006","journal-title":"Frontiers in Bioscience"},{"key":"R30-4-20210202","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1056\/NEJM200008173430707","article-title":"Epstein-Barr virus infection","volume":"343","author":"Cohen","year":"2000","journal-title":"New Engl J Med"},{"key":"R31-4-20210202","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0065-230X(00)79006-3","article-title":"Epstein-Barr virus latency: LMP2, a regulator or means for Epstein-Barr virus persistence?","volume":"79","author":"Longnecker","year":"2000","journal-title":"Adv Cancer Res"},{"key":"R32-4-20210202","doi-asserted-by":"crossref","first-page":"5105","DOI":"10.1002\/j.1460-2075.1993.tb06205.x","article-title":"The (YXXL\/I)2 signalling motif found in the cytoplasmic segments of the bovine leukaemia virus envelope protein and Epstein-Barr virus latent membrane protein 2A can elicit early and late lymphocyte activation events","volume":"12","author":"Beaufils","year":"1993","journal-title":"EMBO J"},{"key":"R33-4-20210202","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1128\/JVI.67.4.2006-2013.1993","article-title":"The last seven transmembrane and carboxy-terminal cytoplasmic domains of Epstein-Barr virus latent membrane protein 2 (LMP2) are dispensable for lymphocyte infection and growth transformation in vitro","volume":"67","author":"Longnecker","year":"1993","journal-title":"J Virol"},{"key":"R34-4-20210202","doi-asserted-by":"crossref","first-page":"5068","DOI":"10.1128\/JVI.67.8.5068-5074.1993","article-title":"Deletion of DNA encoding the first five transmembrane domains of Epstein-Barr virus latent membrane proteins 2A and 2B","volume":"67","author":"Longnecker","year":"1993","journal-title":"J Virol"},{"key":"R35-4-20210202","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1099\/0022-1317-80-8-2193","article-title":"Epstein-Barr virus lacking latent membrane protein 2 immortalizes B cells with efficiency indistinguishable from that of wild-type virus","volume":"80","author":"Speck","year":"1999","journal-title":"J Gen Virol"},{"key":"R36-4-20210202","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/35095584","article-title":"Epstein-Barr virus: exploiting the immune system","volume":"1","author":"Thorley-Lawson","year":"2001","journal-title":"Nat Rev Immunol"},{"key":"R37-4-20210202","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1056\/NEJM198910193211604","article-title":"Expression of Epstein-Barr virus transformation-associated genes in tissues of patients with EBV lymphoproliferative disease","volume":"321","author":"Young","year":"1989","journal-title":"N Engl J Med"},{"key":"R38-4-20210202","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1146\/annurev.immunol.15.1.405","article-title":"Human cytotoxic T lymphocyte responses to Epstein-Barr virus infection","volume":"15","author":"Rickinson","year":"1997","journal-title":"Annu Rev Immunol"},{"key":"R39-4-20210202","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/375685a0","article-title":"Inhibition of antigen processing by the internal repeat region of the Epstein-Barr virus nuclear antigen-1","volume":"375","author":"Levitskaya","year":"1995","journal-title":"Nature"},{"key":"R40-4-20210202","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1002\/ijc.2910420305","article-title":"Expression of Epstein-Barr virus-encoded proteins in nasopharyngeal carcinoma","volume":"42","author":"Fahraeus","year":"1988","journal-title":"Int J Cancer"},{"key":"R41-4-20210202","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/(SICI)1097-0215(19961104)68:3<285::AID-IJC3>3.0.CO;2-Y","article-title":"Nasal NK- and T-cell lymphomas share the same type of Epstein-Barr virus latency as nasopharyngeal carcinoma and Hodgkin's disease","volume":"68","author":"Chiang","year":"1996","journal-title":"Int J Cancer"},{"key":"R42-4-20210202","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1084\/jem.177.2.339","article-title":"Epstein-Barr virus and Hodgkin's disease: transcriptional analysis of virus latency in the malignant cells","volume":"177","author":"Deacon","year":"1993","journal-title":"J Exp Med"},{"key":"R43-4-20210202","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/340393a0","article-title":"Genetic analysis of immortalizing functions of Epstein-Barr virus in human B lymphocytes","volume":"340","author":"Hammerschmidt","year":"1989","journal-title":"Nature"},{"key":"R44-4-20210202","first-page":"1858","article-title":"Infection of leukaemic B lymphocytes by Epstein Barr virus","volume":"7","author":"Doyle","year":"1993","journal-title":"Leukemia"},{"key":"R45-4-20210202","first-page":"347","article-title":"Interaction of Epstein-Barr virus with leukaemic B cells in vitro. I. Abortive infection and rare cell line establishment from chronic lymphocytic leukaemic cells","volume":"50","author":"Rickinson","year":"1982","journal-title":"Clin Exp Immunol"},{"key":"R46-4-20210202","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1159\/000149129","article-title":"Analysis of the transformation of human lymphocytes by Epstein-Barr virus. II. Abortive response of leukemic cells to the transforming virus","volume":"13","author":"Takada","year":"1980","journal-title":"Intervirology"},{"key":"R47-4-20210202","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1002\/ijc.2910440517","article-title":"Activation and immortalization of leukaemic B cells by Epstein-Barr virus","volume":"44","author":"Walls","year":"1989","journal-title":"Int J Cancer"},{"key":"R48-4-20210202","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/345447a0","article-title":"Morphological transformation of human keratinocytes expressing the LMP gene of Epstein-Barr virus","volume":"345","author":"Fahraeus","year":"1990","journal-title":"Nature"},{"key":"R49-4-20210202","doi-asserted-by":"crossref","first-page":"3407","DOI":"10.1128\/JVI.64.7.3407-3416.1990","article-title":"Epstein-Barr virus nuclear antigen 2 transactivates latent membrane protein LMP1","volume":"64","author":"Wang","year":"1990","journal-title":"J Virol"},{"key":"R50-4-20210202","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1016\/S0140-6736(95)90960-5","article-title":"Epstein-Barr-virus-infected nasopharyngeal intraepithelial lymphocytes","volume":"345","author":"Tao","year":"1995","journal-title":"Lancet"},{"key":"R51-4-20210202","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/modpathol.3800369","article-title":"Distribution and phenotype of Epstein-Barr- virus-infected cells in human pharyngeal tonsils","volume":"18","author":"Hudnall","year":"2005","journal-title":"Mod Pathol"},{"key":"R52-4-20210202","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1097\/00019606-199203000-00037","article-title":"Description of an in situ hybridization methodology for detection of Epstein-Barr virus RNA in paraffin-embedded tissues, with a survey of normal and neoplastic tissues","volume":"1","author":"Chang","year":"1992","journal-title":"Diagn Mol Pathol"},{"key":"R53-4-20210202","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/S1074-7613(02)00318-7","article-title":"The dispersal of mucosal memory B cells: evidence from persistent EBV infection","volume":"16","author":"Laichalk","year":"2002","journal-title":"Immunity"},{"key":"R54-4-20210202","doi-asserted-by":"crossref","first-page":"2520","DOI":"10.1182\/blood.V79.10.2520.bloodjournal79102520","article-title":"Patterns of Epstein-Barr virus infection in non-neoplastic lymphoid tissue","volume":"79","author":"Niedobitek","year":"1992","journal-title":"Blood"},{"key":"R55-4-20210202","first-page":"2397","article-title":"Fields Virology. 3rd ed","author":"Rickinson","year":"1996"},{"key":"R56-4-20210202","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1146\/annurev.immunol.15.1.405","article-title":"Human cytotoxic T lymphocyte responses to Epstein-Barr virus infection","volume":"15","author":"Rickinson","year":"1997","journal-title":"Annu Rev Immunol"},{"key":"R57-4-20210202","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1038\/nm0896-906","article-title":"Large clonal expansions of CD8+ T cells in acute infectious mononucleosis","volume":"2","author":"Callan","year":"1996","journal-title":"Nat Med"},{"key":"R58-4-20210202","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1038\/sj.onc.1210240","article-title":"Epstein-Barr virus infection in humans: from harmless to life endangering virus-lymphocyte interactions","volume":"26","author":"Klein","year":"2007","journal-title":"Oncogene"},{"key":"R59-4-20210202","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1126\/science.2161559","article-title":"Homology of cytokine synthesis inhibitory factor (IL-10) to the Epstein-Barr virus gene BCRFI","volume":"248","author":"Moore","year":"1990","journal-title":"Science"},{"key":"R60-4-20210202","doi-asserted-by":"crossref","first-page":"7627","DOI":"10.1128\/JVI.73.9.7627-7632.1999","article-title":"Epstein-Barr virus BARF1 protein is dispensable for B-cell transformation and inhibits alpha interferon secretion from mononuclear cells","volume":"73","author":"Cohen","year":"1999","journal-title":"J Virol"},{"key":"R61-4-20210202","doi-asserted-by":"crossref","first-page":"8479","DOI":"10.1073\/pnas.90.18.8479","article-title":"Epstein-Barr virus-coded BHRF1 protein, a viral homologue of Bcl-2, protects human B cells from programmed cell death","volume":"90","author":"Henderson","year":"1993","journal-title":"Proc Nat Acad Sci USA"},{"key":"R62-4-20210202","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/ijc.2910170105","article-title":"EBV-determined nuclear antigen (EBNA)-positive cells in the peripheral blood of infectious mononucleosis patients","volume":"17","author":"Klein","year":"1976","journal-title":"Int J Cancer"},{"key":"R63-4-20210202","doi-asserted-by":"crossref","first-page":"3042","DOI":"10.1172\/JCI32377","article-title":"HLA class I polymorphisms are associated with development of infectious mononucleosis upon primary EBV infection","volume":"117","author":"McAulay","year":"2007","journal-title":"J Clin Invest"},{"key":"R64-4-20210202","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0140-6736(78)91744-0","article-title":"Persistent Epstein-Barr virus infection in a child with hypergammaglobulinaemia and immunoblastic proliferation associated with a selective defect in immune interferon secretion","volume":"2","author":"Virelizier","year":"1978","journal-title":"Lancet"},{"key":"R65-4-20210202","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1182\/blood.V91.6.2085","article-title":"A syndrome of peripheral blood T-cell infection with Epstein-Barr virus (EBV) followed by EBV-positive T-cell lymphoma","volume":"91","author":"Kanegane","year":"1998","journal-title":"Blood"},{"key":"R66-4-20210202","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1182\/blood.V96.2.443","article-title":"Fulminant EBV(+) T-cell lymphoproliferative disorder following acute\/chronic EBV infection: a distinct clinicopathologic syndrome","volume":"96","author":"Quintanilla-Martinez","year":"2000","journal-title":"Blood"},{"key":"R67-4-20210202","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1086\/367988","article-title":"Prognostic factors for chronic active Epstein-Barr virus infection","volume":"187","author":"Kimura","year":"2003","journal-title":"J Infect Dis"},{"key":"R68-4-20210202","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1182\/blood.V98.2.280","article-title":"Clinical and virologic characteristics of chronic active Epstein-Barr virus infection","volume":"98","author":"Kimura","year":"2001","journal-title":"Blood"},{"key":"R69-4-20210202","first-page":"1165","article-title":"Clinicopathological states of Epstein-Barr virus-associated T\/NK-cell lymphoproliferative disorders (severe chronic active EBV infection) of children and young adults","volume":"24","author":"Suzuki","year":"2004","journal-title":"Int J Oncol"},{"key":"R70-4-20210202","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1002\/(SICI)1097-0215(19970611)71:6<943::AID-IJC5>3.0.CO;2-Y","article-title":"Integrated Epstein-Barr virus (EBV) and chromosomal abnormality in chronic active EBV infection","volume":"71","author":"Ohshima","year":"1997","journal-title":"Int J Cancer"},{"key":"R71-4-20210202","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1093\/infdis\/160.3.546a","article-title":"Chronic active Epstein-Barr virus (EBV) infection is associated with clonotypic intracellular terminal regions of the EBV","volume":"160","author":"Kikuta","year":"1989","journal-title":"J Infect Dis"},{"key":"R72-4-20210202","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1046\/j.1365-2141.2003.04359.x","article-title":"Common cytological and cytogenetic features of Epstein-Barr virus (EBV)-positive natural killer (NK) cells and cell lines derived from patients with nasal T\/NK-cell lymphomas, chronic active EBV infection and hydroa vacciniforme-like eruptions","volume":"121","author":"Zhang","year":"2003","journal-title":"Br J Haematol"},{"key":"R73-4-20210202","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/S0037-1963(03)70004-3","article-title":"Epstein-Barr virus-associated T-\/natural killer cell lymphoproliferative diseases","volume":"40","author":"Yachie","year":"2003","journal-title":"Semin Hematol"},{"key":"R74-4-20210202","first-page":"278","article-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. 4th ed","author":"Quintanilla-Martinez","year":"2008"},{"key":"R75-4-20210202","first-page":"262","article-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","author":"Leoncini","year":"2008"},{"key":"R76-4-20210202","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1002\/path.2384","article-title":"The Epstein-Barr virus oncoprotein, latent membrane protein-1, reprograms germinal centre B cells towards a Hodgkin's Reed-Sternberg-like phenotype","volume":"216","author":"Vockerodt","year":"2008","journal-title":"J Pathol"},{"key":"R77-4-20210202","doi-asserted-by":"crossref","first-page":"2825","DOI":"10.1182\/blood-2007-06-096784","article-title":"MicroRNA expression profiling in classic Hodgkin lymphoma","volume":"111","author":"Navarro","year":"2008","journal-title":"Blood"},{"key":"R78-4-20210202","doi-asserted-by":"crossref","first-page":"2216","DOI":"10.1016\/S0140-6736(05)66780-3","article-title":"Association with HLA class I in Epstein-Barr-virus-positive and with HLA class III in Epstein-Barr-virus-negative Hodgkin's lymphoma","volume":"365","author":"Diepstra","year":"2005","journal-title":"Lancet"},{"key":"R79-4-20210202","doi-asserted-by":"crossref","first-page":"3310","DOI":"10.1182\/blood-2007-05-086934","article-title":"HLA-A*02 is associated with a reduced risk and HLA-A*01 with an increased risk of developing EBV+ Hodgkin lymphoma","volume":"110","author":"Niens","year":"2007","journal-title":"Blood"},{"key":"R80-4-20210202","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1054\/bjoc.2001.1774","article-title":"Assessment of the prognostic impact of the Epstein-Barr virus-encoded latent membrane protein-1 expression in Hodgkin's disease","volume":"84","author":"Glavina-Durdov","year":"2001","journal-title":"Br J Cancer"},{"key":"R81-4-20210202","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1097\/01.MP.0000071843.09960.BF","article-title":"Longer failure-free survival interval of Epstein-Barr virus-associated classical Hodgkin's lymphoma: a single-institution study","volume":"16","author":"Krugmann","year":"2003","journal-title":"Mod Pathol"},{"key":"R82-4-20210202","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S0065-230X(02)84009-X","article-title":"Molecular biology of Hodgkin's lymphoma","volume":"84","author":"Kuppers","year":"2002","journal-title":"Adv Cancer Res"},{"key":"R83-4-20210202","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1084\/jem.184.4.1495","article-title":"Hodgkin and Reed-Sternberg cells in Hodgkin's disease represent the outgrowth of a dominant tumor clone derived from (crippled) germinal center B cells","volume":"184","author":"Kanzler","year":"1996","journal-title":"J Exp Med"},{"key":"R84-4-20210202","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1182\/blood.V95.4.1443.004k55_1443_1450","article-title":"Hodgkin and Reed-Sternberg cells represent an expansion of a single clone originating from a germinal center B-cell with functional immunoglobulin gene rearrangements but defective immunoglobulin transcription","volume":"95","author":"Marafioti","year":"2000","journal-title":"Blood"},{"key":"R85-4-20210202","doi-asserted-by":"crossref","first-page":"3191","DOI":"10.1182\/blood.V97.10.3191","article-title":"Defective octamer-dependent transcription is responsible for silenced immunoglobulin transcription in Reed-Sternberg cells","volume":"97","author":"Theil","year":"2001","journal-title":"Blood"},{"key":"R86-4-20210202","doi-asserted-by":"crossref","first-page":"2961","DOI":"10.1172\/JCI119849","article-title":"Constitutive nuclear factor-kappaB-RelA activation is required for proliferation and survival of Hodgkin's disease tumor cells","volume":"100","author":"Bargou","year":"1997","journal-title":"J Clin Invest"},{"key":"R87-4-20210202","doi-asserted-by":"crossref","first-page":"6496","DOI":"10.1128\/JVI.66.11.6496-6501.1992","article-title":"Epstein-Barr virus latent membrane protein transactivates the human immunodeficiency virus type 1 long terminal repeat through induction of NF-kappa B activity","volume":"66","author":"Hammarskjold","year":"1992","journal-title":"J Virol"},{"key":"R88-4-20210202","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/S1074-7613(00)80623-8","article-title":"Epstein-Barr virus LMP2A drives B cell development and survival in the absence of normal B cell receptor signals","volume":"9","author":"Caldwell","year":"1998","journal-title":"Immunity"},{"key":"R89-4-20210202","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.1038\/sj.onc.1202893","article-title":"Mutations in the IkBa gene in Hodgkin's disease suggest a tumour suppressor role for IkappaBalpha","volume":"18","author":"Cabannes","year":"1999","journal-title":"Oncogene"},{"key":"R90-4-20210202","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1084\/jem.191.2.395","article-title":"Clonal deleterious mutations in the IkappaBalpha gene in the malignant cells in Hodgkin's lymphoma","volume":"191","author":"Jungnickel","year":"2000","journal-title":"J Exp Med"},{"key":"R91-4-20210202","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1182\/blood.V99.4.1474","article-title":"Recurrent involvement of the REL and BCL11A loci in classical Hodgkin lymphoma","volume":"99","author":"Martin-Subero","year":"2002","journal-title":"Blood"},{"key":"R92-4-20210202","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1038\/sj.onc.1205337","article-title":"Ligand-independent signaling by overexpressed CD30 drives NF-kappaB activation in Hodgkin-Reed-Sternberg cells","volume":"21","author":"Horie","year":"2002","journal-title":"Oncogene"},{"key":"R93-4-20210202","first-page":"185","article-title":"World Health Organization Classification of Tumors Pathology and Genetics of Tumors of Hematopoietic and Lymphoid Tissues","author":"Jaffe","year":"2001"},{"key":"R94-4-20210202","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1002\/1097-0142(197901)43:1<360::AID-CNCR2820430151>3.0.CO;2-8","article-title":"Lymphomatoid granulomatosis: a clinicopathologic study of 152 cases","volume":"43","author":"Katzenstein","year":"1979","journal-title":"Cancer"},{"key":"R95-4-20210202","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1097\/00000478-199408000-00001","article-title":"Pulmonary lymphomatoid granulomatosis. Evidence for a proliferation of Epstein-Barr virus infected B-lymphocytes with a prominent T-cell component and vasculitis","volume":"18","author":"Guinee","year":"1994","journal-title":"Am J Surg Pathol"},{"key":"R96-4-20210202","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1097\/00000478-199511000-00011","article-title":"Lymphomatoid granulomatosis. Evidence of immunophenotypic diversity and relationship to Epstein-Barr virus infection","volume":"19","author":"Myers","year":"1995","journal-title":"Am J Surg Pathol"},{"key":"R97-4-20210202","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/j.1365-2559.1996.tb01415.x","article-title":"Lymphomatoid granulomatosis: evidence that some cases represent Epstein-Barr virus-associated B-cell lymphoma","volume":"29","author":"Nicholson","year":"1996","journal-title":"Histopathology"},{"key":"R98-4-20210202","doi-asserted-by":"crossref","first-page":"4531","DOI":"10.1182\/blood.V87.11.4531.bloodjournal87114531","article-title":"Association of lymphomatoid granulomatosis with Epstein-Barr viral infection of B lymphocytes and response to interferon-alpha 2b","volume":"87","author":"Wilson","year":"1996","journal-title":"Blood"},{"key":"R99-4-20210202","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1182\/blood.V72.5.1674.1674","article-title":"Angiocentric immunoproliferative lesions: a clinicopathologic spectrum of post-thymic T-cell proliferations","volume":"72","author":"Lipford","year":"1988","journal-title":"Blood"},{"key":"R100-4-20210202","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1183\/09031936.98.12010102","article-title":"Lymphomatoid granulomatosis\u2013a report on four cases: evidence for B phenotype of the tumoral cells","volume":"12","author":"Taniere","year":"1998","journal-title":"Eur Respir J"},{"key":"R101-4-20210202","first-page":"245","article-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","author":"Chan","year":"2008"},{"key":"R102-4-20210202","first-page":"249","article-title":"Non-Hodgkin's lymphoma of the pleural cavity developing from long-standing pyothorax. Summary of clinical and pathological findings in thirty-seven cases","volume":"19","author":"Iuchi","year":"1989","journal-title":"Jpn J Clin Oncol"},{"key":"R103-4-20210202","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1002\/1097-0142(19871015)60:8<1771::AID-CNCR2820600817>3.0.CO;2-2","article-title":"Non-Hodgkin's lymphoma of the pleural cavity developing from long-standing pyothorax","volume":"60","author":"Iuchi","year":"1987","journal-title":"Cancer"},{"key":"R104-4-20210202","doi-asserted-by":"crossref","first-page":"4255","DOI":"10.1200\/JCO.2002.09.021","article-title":"Pyothorax-associated lymphoma: a review of 106 cases","volume":"20","author":"Nakatsuka","year":"2002","journal-title":"J Clin Oncol"},{"key":"R105-4-20210202","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1111\/j.1440-1827.1995.tb03402.x","article-title":"Pyothorax-associated lymphoma: development of Epstein-Barr virus-associated lymphoma within the inflammatory cavity","volume":"45","author":"Fukayama","year":"1995","journal-title":"Pathol Int"},{"key":"R106-4-20210202","first-page":"1044","article-title":"Epstein-Barr virus in pyothorax-associated pleural lymphoma","volume":"143","author":"Fukayama","year":"1993","journal-title":"Am J Pathol"},{"key":"R107-4-20210202","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1093\/annonc\/mdl349","article-title":"Clinicopathological features of pyothorax-associated lymphoma; a retrospective survey involving 98 patients","volume":"18","author":"Narimatsu","year":"2007","journal-title":"Ann Oncol"},{"key":"R108-4-20210202","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1097\/00000478-200301000-00003","article-title":"Senile EBV+ B-cell lymphoproliferative disorders: a clinicopathologic study of 22 patients","volume":"27","author":"Oyama","year":"2003","journal-title":"Am J Surg Pathol"},{"key":"R109-4-20210202","first-page":"243","article-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. 4th ed","author":"Nakamura","year":"2008"},{"key":"R110-4-20210202","doi-asserted-by":"crossref","first-page":"5124","DOI":"10.1158\/1078-0432.CCR-06-2823","article-title":"Age-related EBV-associated B-cell lymphoproliferative disorders constitute a distinct clinicopathologic group: a study of 96 patients","volume":"13","author":"Oyama","year":"2007","journal-title":"Clin Cancer Res"},{"key":"R111-4-20210202","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1111\/j.1349-7006.2008.00813.x","article-title":"Age-related Epstein-Barr virus-associated B-cell lymphoproliferative disorders: special references to lymphomas surrounding this newly recognized clinicopathologic disease","volume":"99","author":"Shimoyama","year":"2008","journal-title":"Cancer Sci"},{"key":"R112-4-20210202","first-page":"285","article-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. 4th ed","author":"Chan","year":"2008"},{"key":"R113-4-20210202","doi-asserted-by":"crossref","first-page":"4501","DOI":"10.1182\/blood.V89.12.4501","article-title":"Nonnasal lymphoma expressing the natural killer cell marker CD56: a clinicopathologic study of 49 cases of an uncommon aggressive neoplasm","volume":"89","author":"Chan","year":"1997","journal-title":"Blood"},{"key":"R114-4-20210202","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1309\/2F39NX1AL3L54WU8","article-title":"NK-cell lymphomas and leukemias: a spectrum of tumors with variable manifestations and immunophenotype","volume":"127","author":"Hasserjian","year":"2007","journal-title":"Am J Clin Pathol"},{"key":"R115-4-20210202","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/0002-9343(83)90402-3","article-title":"Malignant lymphoma and erythrophagocytosis simulating malignant histiocytosis","volume":"75","author":"Jaffe","year":"1983","journal-title":"Am J Med"},{"key":"R116-4-20210202","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1002\/hon.2900080505","article-title":"Presence of Epstein-Barr virus DNA in nasal lymphomas of B and \u2018T\u2019 cell type","volume":"8","author":"Ho","year":"1990","journal-title":"Hematol Oncol"},{"key":"R117-4-20210202","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/ijc.2910600306","article-title":"Epstein-Bar virus is localized in the tumour cells of nasal lymphomas of NK, T or B cell type","volume":"60","author":"Tao","year":"1995","journal-title":"Int J Cancer"},{"key":"R118-4-20210202","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1054\/bjoc.2000.1687","article-title":"The latency pattern of Epstein-Barr virus infection and viral IL-10 expression in cutaneous natural killer\/T-cell lymphomas","volume":"84","author":"Xu","year":"2001","journal-title":"Br J Cancer"},{"key":"R119-4-20210202","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1038\/modpathol.3800157","article-title":"Nasal-type extranodal natural killer\/T-cell lymphomas: a clinicopathologic and genotypic study of 42 cases in Singapore","volume":"17","author":"Ng","year":"2004","journal-title":"Mod Pathol"},{"key":"R120-4-20210202","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/S0046-8177(96)90401-3","article-title":"Differences in T-cell-receptor gene rearrangement and transcription in nasal lymphomas of natural killer and T-cell types: implications on cellular origin","volume":"27","author":"Chiang","year":"1996","journal-title":"Hum Pathol"},{"key":"R121-4-20210202","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1046\/j.1365-2141.2003.04419.x","article-title":"A 2.6 Mb interval on chromosome 6q25.2-q25.3 is commonly deleted in human nasal natural killer\/T-cell lymphoma","volume":"122","author":"Sun","year":"2003","journal-title":"Br J Haematol"},{"key":"R122-4-20210202","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1016\/S0002-9440(10)64818-3","article-title":"Consistent patterns of allelic loss in natural killer cell lymphoma","volume":"157","author":"Siu","year":"2000","journal-title":"Am J Pathol"},{"key":"R123-4-20210202","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1002\/1097-0142(20001115)89:10<2106::AID-CNCR11>3.0.CO;2-G","article-title":"Clinicopathologic and genotypic study of extranodal nasal-type natural killer\/T-cell lymphoma and natural killer precursor lymphoma among Koreans","volume":"89","author":"Ko","year":"2000","journal-title":"Cancer"},{"key":"R124-4-20210202","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.1182\/blood-2003-01-0295","article-title":"CD94 transcripts imply a better prognosis in nasal-type extranodal NK\/T-cell lymphoma","volume":"102","author":"Lin","year":"2003","journal-title":"Blood"},{"key":"R125-4-20210202","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1093\/annonc\/mdm183","article-title":"Ki-67 expression is predictive of prognosis in patients with stage I\/II extranodal NK\/T-cell lymphoma, nasal type","volume":"18","author":"Kim","year":"2007","journal-title":"Ann Oncol"},{"key":"R126-4-20210202","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1309\/MN4Y8HLQWKD9NB5E","article-title":"EBV viral load in tumor tissue is an important prognostic indicator for nasal NK\/T-cell lymphoma","volume":"128","author":"Hsieh","year":"2007","journal-title":"Am J Clin Pathol"},{"key":"R127-4-20210202","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1002\/jmv.20853","article-title":"Clinical usefulness of serum EBV DNA levels of BamHI W and LMP1 for Nasal NK\/T-cell lymphoma","volume":"79","author":"Ishii","year":"2007","journal-title":"J Med Virol"},{"key":"R128-4-20210202","first-page":"1139","article-title":"Diagnostic Histopathology of Tumors. 3rd ed","author":"Chan","year":"2007"},{"key":"R129-4-20210202","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/j.1365-2141.1990.tb02615.x","article-title":"Aggressive natural killer cell leukaemia\/lymphoma: report of four cases and review of the literature. Possible existence of a new clinical entity originating from the third lineage of lymphoid cells","volume":"75","author":"Imamura","year":"1990","journal-title":"Br J Haematol"},{"key":"R130-4-20210202","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1046\/j.1365-2559.2000.00936.x","article-title":"Lymphomatous features of aggressive NK cell leukaemia\/lymphoma with massive necrosis, haemophagocytosis and EB virus infection","volume":"37","author":"Mori","year":"2000","journal-title":"Histopathology"},{"key":"R131-4-20210202","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1046\/j.1365-2559.2000.01029.x","article-title":"Commentary: aggressive NK cell lymphomas: insights into the spectrum of NK cell derived malignancies","volume":"37","author":"Quintanilla-Martinez","year":"2000","journal-title":"Histopathology"},{"key":"R132-4-20210202","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/01.pap.0000151318.34752.80","article-title":"The pathology of NK-cell lymphomas and leukemias","volume":"12","author":"Nava","year":"2005","journal-title":"Adv Anat Pathol"},{"key":"R133-4-20210202","first-page":"77","article-title":"Natural killer cell neoplasms","volume":"3","author":"Chan","year":"1998","journal-title":"Anat Pathol"},{"key":"R134-4-20210202","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1111\/j.1365-2141.1994.tb04804.x","article-title":"Aggressive natural killer cell leukaemia\/lymphoma in two patients with lethal midline granuloma","volume":"86","author":"Soler","year":"1994","journal-title":"Br J Haematol"},{"key":"R135-4-20210202","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1002\/gcc.20245","article-title":"Genome-wide array-based comparative genomic hybridization of natural killer cell lymphoma\/leukemia: different genomic alteration patterns of aggressive NK-cell leukemia and extranodal Nk\/T-cell lymphoma, nasal type","volume":"44","author":"Nakashima","year":"2005","journal-title":"Genes Chromosomes Cancer"},{"key":"R136-4-20210202","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1016\/S0002-9440(10)65454-5","article-title":"Comparative genomic hybridization analysis of natural killer cell lymphoma\/leukemia. Recognition of consistent patterns of genetic alterations","volume":"155","author":"Siu","year":"1999","journal-title":"Am J Pathol"},{"key":"R137-4-20210202","doi-asserted-by":"crossref","first-page":"241","DOI":"10.3109\/10428199909050949","article-title":"Cytogenetic abnormalities in natural killer cell lymphoma\/leukaemia\u2013is there a consistent pattern?","volume":"34","author":"Wong","year":"1999","journal-title":"Leukemia Lymphoma"},{"key":"R138-4-20210202","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/j.1440-1827.2008.02213.x","article-title":"Proposed categorization of pathological states of EBV-associated T\/natural killer-cell lymphoproliferative disorder (LPD) in children and young adults: overlap with chronic active EBV infection and infantile fulminant EBV T-LPD","volume":"58","author":"Ohshima","year":"2008","journal-title":"Pathol Int"},{"key":"R139-4-20210202","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1046\/j.1365-2230.2001.00805.x","article-title":"Epstein-Barr virus-associated peripheral T-cell lymphoma in adults with hydroa vacciniforme-like lesions","volume":"26","author":"Cho","year":"2001","journal-title":"Clin Exp Dermatol"},{"key":"R140-4-20210202","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1046\/j.1365-2133.1999.02777.x","article-title":"The association of latent Epstein-Barr virus infection with hydroa vacciniforme","volume":"140","author":"Iwatsuki","year":"1999","journal-title":"Br J Dermatol"},{"key":"R141-4-20210202","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1002\/rmv.505","article-title":"Pathogenesis of chronic active Epstein-Barr virus infection: is this an infectious disease, lymphoproliferative disorder, or immunodeficiency?","volume":"16","author":"Kimura","year":"2006","journal-title":"Rev Med Virol"},{"key":"R142-4-20210202","first-page":"952","article-title":"Detection of clonal Epstein-Barr virus in malignant proliferation of peripheral blood CD3+ CD8+ T cells","volume":"6","author":"Chan","year":"1992","journal-title":"Leukemia"},{"key":"R143-4-20210202","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.1002\/1097-0142(19901215)66:12<2557::AID-CNCR2820661218>3.0.CO;2-2","article-title":"Epstein-Barr virus-associated peripheral T-cell lymphoma of activated CD8 phenotype","volume":"66","author":"Su","year":"1990","journal-title":"Cancer"},{"key":"R144-4-20210202","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1007\/BF01954490","article-title":"Monoclonal proliferation of Epstein-Barr virus-infected T cells in a patient with virus-associated haemophagocytic syndrome","volume":"153","author":"Noma","year":"1994","journal-title":"Eur J Pediatr"},{"key":"R145-4-20210202","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/0046-8177(93)90195-M","article-title":"A case of fatal infectious mononucleosis presenting with fulminant hepatic failure associated with an extensive CD8-positive lymphocyte infiltration in the liver","volume":"24","author":"Tazawa","year":"1993","journal-title":"Hum Pathol"},{"key":"R146-4-20210202","doi-asserted-by":"crossref","first-page":"3259","DOI":"10.1182\/blood.V82.11.3259.3259","article-title":"Fatal Epstein-Barr virus-associated hemophagocytic syndrome","volume":"82","author":"Kikuta","year":"1993","journal-title":"Blood"},{"key":"R147-4-20210202","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1182\/blood.V98.6.1882","article-title":"Differential cellular targets of Epstein-Barr virus (EBV) infection between acute EBV-associated hemophagocytic lymphohistiocytosis and chronic active EBV infection","volume":"98","author":"Kasahara","year":"2001","journal-title":"Blood"},{"key":"R148-4-20210202","first-page":"1219","article-title":"Epstein-Barr virus (EBV) infects T lymphocytes in childhood EBV-associated hemophagocytic syndrome in Taiwan","volume":"144","author":"Su","year":"1994","journal-title":"Am J Pathol"},{"key":"R149-4-20210202","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0037-1963(03)00132-X","article-title":"Classification of cytotoxic T-cell and natural killer cell lymphomas","volume":"40","author":"Jaffe","year":"2003","journal-title":"Semin Hematol"},{"key":"R150-4-20210202","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1309\/QBLAMA321K9AD2XK","article-title":"Morphologic and immunophenotypic variants of nodal T-cell lymphomas and T-cell lymphoma mimics","volume":"127","author":"Warnke","year":"2007","journal-title":"Am J Clin Pathol"},{"key":"R151-4-20210202","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1097\/01.pas.0000209855.28282.ce","article-title":"Programmed death-1 (PD-1) is a marker of germinal center-associated T cells and angioimmunoblastic T-cell lymphoma","volume":"30","author":"Dorfman","year":"2006","journal-title":"Am J Surg Pathol"},{"key":"R152-4-20210202","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1309\/6UTX-GVC0-12ND-JJEU","article-title":"Epstein-Barr virus-associated B-cell lymphoproliferative disorders in angloimmunoblastic T-cell lymphoma and peripheral T-cell lymphoma, unspecified","volume":"117","author":"Zettl","year":"2002","journal-title":"Am J Clin Pathol"},{"key":"R153-4-20210202","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1097\/00000478-199910000-00008","article-title":"Peripheral T-cell lymphoma with Reed-Sternberg-like cells of B-cell phenotype and genotype associated with Epstein-Barr virus infection","volume":"23","author":"Quintanilla-Martinez","year":"1999","journal-title":"Am J Surg Pathol"},{"key":"R154-4-20210202","first-page":"1862","article-title":"Post-transplantation lymphoproliferative disorders arising in solid organ transplant recipients are usually of recipient origin","volume":"147","author":"Chadburn","year":"1995","journal-title":"Am J Pathol"},{"key":"R155-4-20210202","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1182\/blood.V85.2.552.552","article-title":"Correlative morphologic and molecular genetic analysis demonstrates three distinct categories of posttransplantation lymphoproliferative disorders","volume":"85","author":"Knowles","year":"1995","journal-title":"Blood"},{"key":"R156-4-20210202","doi-asserted-by":"crossref","first-page":"10411","DOI":"10.1073\/pnas.93.19.10411","article-title":"c-myc activation renders proliferation of Epstein-Barr virus (EBV)-transformed cells independent of EBV nuclear antigen 2 and latent membrane protein 1","volume":"93","author":"Polack","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"key":"R157-4-20210202","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1182\/blood.V92.7.2294","article-title":"BCL-6 gene mutations in posttransplantation lymphoproliferative disorders predict response to therapy and clinical outcome","volume":"92","author":"Cesarman","year":"1998","journal-title":"Blood"},{"key":"R158-4-20210202","article-title":"World Health Organization Classification of Tumors Pathology and Genetics of Tumors of Hematopoietic and Lymphoid Tissues","author":"Raphael","year":"2001"},{"key":"R159-4-20210202","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/0140-6736(91)92513-2","article-title":"AIDS-associated non-Hodgkin lymphoma","volume":"337","author":"Beral","year":"1991","journal-title":"Lancet"},{"key":"R160-4-20210202","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1097\/01.pas.0000173023.02724.1f","article-title":"Plasmablastic lymphoma in HIV-positive patients: an aggressive Epstein-Barr virus-associated extramedullary plasmacytic neoplasm","volume":"29","author":"Dong","year":"2005","journal-title":"Am J Surg Pathol"},{"key":"R161-4-20210202","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.anndiagpath.2005.07.009","article-title":"Plasmablastic lymphoma: a clinicopathologic correlation","volume":"10","author":"Folk","year":"2006","journal-title":"Ann Diagn Pathol"},{"key":"R162-4-20210202","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1073\/pnas.90.1.352","article-title":"Plasmacytoid differentiation of Epstein-Barr virus-transformed B cells in vivo is associated with reduced expression of viral latent genes","volume":"90","author":"Rochford","year":"1993","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R163-4-20210202","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1128\/JVI.79.2.1244-1251.2005","article-title":"Distinct subsets of primary effusion lymphoma can be identified based on their cellular gene expression profile and viral association","volume":"79","author":"Fan","year":"2005","journal-title":"J Virol"},{"key":"R164-4-20210202","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1099\/0022-1317-79-6-1445","article-title":"Restricted expression of Epstein-Barr virus (EBV)-encoded, growth transformation-associated antigens in an EBV and human herpesvirus type 8-carrying body cavity lymphoma line","volume":"79","author":"Szekely","year":"1998","journal-title":"J Gen Virol"},{"key":"R165-4-20210202","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1016\/S0002-9440(10)65749-5","article-title":"Immunoglobulin VH gene mutational analysis suggests that primary effusion lymphomas derive from different stages of B cell maturation","volume":"153","author":"Matolcsy","year":"1998","journal-title":"Am J Pathol"},{"key":"R166-4-20210202","doi-asserted-by":"crossref","first-page":"3415","DOI":"10.1182\/blood-2002-02-0487","article-title":"KSHV- and EBV-associated germinotropic lymphoproliferative disorder","volume":"100","author":"Du","year":"2002","journal-title":"Blood"},{"key":"R167-4-20210202","first-page":"258","article-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissue. 4th ed","author":"Isaacson","year":"2008"},{"key":"R168-4-20210202","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1309\/Q49CRJ030L22MHLF","article-title":"The immunophenotypic attributes of NK cells and NK-cell lineage lymphoproliferative disorders","volume":"127","author":"Morice","year":"2007","journal-title":"Am J Clin Pathol"}],"container-title":["Advances in Anatomic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/PAP.0b013e3181916029","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:29:56Z","timestamp":1786037396000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00125480-200901000-00004"}},"subtitle":["An Update for the Diagnostic Pathologist"],"short-title":[],"issued":{"date-parts":[[2009,1]]},"references-count":168,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1097\/pap.0b013e3181916029","relation":{},"ISSN":["1072-4109"],"issn-type":[{"value":"1072-4109","type":"print"}],"subject":[],"published":{"date-parts":[[2009,1]]}}}